Global Recombinant Human Serum Albumin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Recombinant Human Serum Albumin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
Recombinant Human Serum Albumin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Human Serum Albumin market is projected to reach US$ 122.2 million in 2034, increasing from US$ 75 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2034. Demand from Cell Culture Media and Medical Supplements are the major drivers for the industry.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Human Serum Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Cell Culture Media
Medical Supplements
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Human Serum Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Human Serum Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Human Serum Albumin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Human Serum Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Human Serum Albumin introduction, etc. Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Recombinant Human Serum Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Recombinant Human Serum Albumin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Human Serum Albumin market is projected to reach US$ 122.2 million in 2034, increasing from US$ 75 million in 2022, with the CAGR of 7.3% during the period of 2024 to 2034. Demand from Cell Culture Media and Medical Supplements are the major drivers for the industry.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Human Serum Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Segment by Type
OsrHSA
ScrHSA
Segment by Application
Cell Culture Media
Medical Supplements
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Human Serum Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Recombinant Human Serum Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Recombinant Human Serum Albumin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Recombinant Human Serum Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Recombinant Human Serum Albumin introduction, etc. Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Recombinant Human Serum Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices